Raed Alserihi
Papers
1
Total Citations
15
H-Index
1
About
Raed Alserihi is pioneering the intersection of bioprinting and hematological oncology, with a primary focus on engineering advanced three-dimensional disease models to study acute myeloid leukemia (AML). His most cited work, published in 2023, introduces a groundbreaking automated robotic multicellular bioprinting system that fabricates a bone marrow niche-like AML model—a significant leap beyond traditional 2D cultures. This innovation, already garnering 15 citations, allows researchers to recapitulate the complex cellular and extracellular microenvironment of the bone marrow, enabling more accurate investigation of drug resistance and disease relapse mechanisms. By precisely controlling the spatial arrangement of leukemic cells, stromal cells, and biomaterials, Alserihi’s approach offers a robust platform for high-throughput screening of novel therapeutics. His contributions are particularly vital for understanding why AML frequently recurs after initial treatment, addressing a critical gap in preclinical modeling. Alserihi’s work exemplifies how biofabrication technologies can transform cancer research, providing tools that more faithfully replicate human pathophysiology and hold promise for accelerating the discovery of effective therapies against this challenging malignancy.
Research Focus
Key Achievements
Top Papers
- 1